Efficacy of Monotherapy with a Three Times-Daily Injection of 50/50 Premix Insulin Analogue in Untreated Patients with Diabetes Mellitus
-
- Ida Kenichi
- Seimei-kai Ikeda Hospital
-
- Usami Masaru
- Seimei-kai Ikeda Hospital
-
- Kimura Yuko
- Seimei-kai Ikeda Hospital
-
- Komatsu Takayuki
- Seimei-kai Ikeda Hospital
-
- Kodama Mitsuaki
- Seimei-kai Ikeda Hospital
-
- Yoshizaki Yuko
- Seimei-kai Ikeda Hospital
-
- Ikeda Hiroki
- Seimei-kai Ikeda Hospital
-
- Ikeda Masaki
- Seimei-kai Ikeda Hospital
Bibliographic Information
- Other Title
-
- 未治療2型糖尿病患者に対する50%混合型インスリンアナログ製剤の3回注射によるインスリン導入の効果
- 診断・治療(食事・運動・薬物治療) 未治療2型糖尿病患者に対する50%混合型インスリンアナログ製剤の3回注射によるインスリン導入の効果
- シンダン ・ チリョウ(ショクジ ・ ウンドウ ・ ヤクブツ チリョウ) ミチリョウ 2ガタ トウニョウビョウ カンジャ ニ タイスル 50%コンゴウガタ インスリンアナログ セイザイ ノ 3カイ チュウシャ ニ ヨル インスリン ドウニュウ ノ コウカ
Search this article
Abstract
We compared two insulin treatments among untreated type 2 patients with diabetes mellitus. One was a 50 % premixed insulin analogue (50/50 premix insulin analogue of intermediate insulin and insulin lispro) three times daily (TID) injection monotherapy and the other was basal-bolus insulin therapy. Those two treatments had almost the same efficacies in the daily profile of plasma glucose levels and HbA1c and therefore both improved the blood glucose levels. However, some advantages were found in the mixed insulin treatment. 50/50 premix insulin analogue TID allowed easier initiation and flexible dose for once or twice a day compared with the basal-bolus regimen.<br>
Journal
-
- Journal of the Japan Diabetes Society
-
Journal of the Japan Diabetes Society 55 (8), 599-605, 2012
THE JAPAN DIABETES SOCIETY
- Tweet
Details 詳細情報について
-
- CRID
- 1390282679885690880
-
- NII Article ID
- 10031123014
-
- NII Book ID
- AN00166576
-
- ISSN
- 1881588X
- 0021437X
-
- NDL BIB ID
- 023965275
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- NDL
- CiNii Articles
-
- Abstract License Flag
- Disallowed